Co-Diagnostics, Inc. (LON:0A50)

Co-Diagnostics Statistics

Total Valuation

Co-Diagnostics has a market cap or net worth of GBP 12.22 million. The enterprise value is 3.62 million.

Market Cap	12.22M
Enterprise Value	3.62M

Important Dates

The next estimated earnings date is Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	38.52M
Shares Outstanding	n/a
Shares Change (YoY)	+6.53%
Shares Change (QoQ)	+3.31%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	35.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	16.68
PB Ratio	0.41
P/TBV Ratio	1.11
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.14
EV / Sales	4.89
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.15

Financial Position

The company has a current ratio of 4.12, with a Debt / Equity ratio of 0.04.

Current Ratio	4.12
Quick Ratio	3.66
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.05
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -63.40% and return on invested capital (ROIC) is -41.11%.

Return on Equity (ROE)	-63.40%
Return on Assets (ROA)	-38.09%
Return on Invested Capital (ROIC)	-41.11%
Return on Capital Employed (ROCE)	-90.64%
Revenue Per Employee	5,550
Profits Per Employee	-199,014
Employee Count	132
Asset Turnover	0.02
Inventory Turnover	0.48

Taxes

In the past 12 months, Co-Diagnostics has paid 27,988 in taxes.

Income Tax	27,988
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -71.60% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-71.60%
50-Day Moving Average	0.30
200-Day Moving Average	0.47
Relative Strength Index (RSI)	62.00
Average Volume (20 Days)	83,539

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.21

Income Statement

In the last 12 months, Co-Diagnostics had revenue of GBP 732,566 and -26.27 million in losses. Loss per share was -0.83.

Revenue	732,566
Gross Profit	290,125
Operating Income	-28.28M
Pretax Income	-26.24M
Net Income	-26.27M
EBITDA	-27.35M
EBIT	-28.28M
Loss Per Share	-0.83

Balance Sheet

The company has 9.75 million in cash and 1.24 million in debt, giving a net cash position of 8.51 million.

Cash & Cash Equivalents	9.75M
Total Debt	1.24M
Net Cash	8.51M
Net Cash Per Share	n/a
Equity (Book Value)	30.03M
Book Value Per Share	0.83
Working Capital	8.46M

Cash Flow

In the last 12 months, operating cash flow was -23.72 million and capital expenditures -540,420, giving a free cash flow of -24.26 million.

Operating Cash Flow	-23.72M
Capital Expenditures	-540,420
Free Cash Flow	-24.26M
FCF Per Share	n/a

Margins

Gross Margin	39.60%
Operating Margin	-3,861.07%
Pretax Margin	-3,582.18%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Co-Diagnostics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.53%
Shareholder Yield	n/a
Earnings Yield	-214.97%
FCF Yield	-198.50%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Co-Diagnostics has an Altman Z-Score of -0.9 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.9
Piotroski F-Score	1